1. VEGF −460C>T polymorphism and cancer risk: a meta-analysis

   • Bin Xu
   • Ning-Han Feng
   • Lin-Xin Hua

   Original Paper 09 October 2009 Pages: 1031 - 1036

   

2. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes

   • Ajay Gupta
   • Mansher Singh
   • Sanjay Thulkar

   Original paper 15 October 2009 Pages: 1037 - 1045

3. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine

   • Salamun Desire
   • Poonkuzhali Balasubramanian
   • Mammen Chandy

   Original paper 15 October 2009 Pages: 1046 - 1049

4. Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center

   • Ozcan Yildiz
   • Mustafa Ozguroglu
   • Gulen Dogusoy

   Original Paper 03 November 2009 Pages: 1050 - 1056

   

5. Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: a case report

   • Keith Siau
   • Mohini Varughese

   Original Paper 22 October 2009 Pages: 1057 - 1059

6. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment

   • Mehmet Aliustaoglu
   • Ahmet Bilici
   • Mahmut Gumus

   Original Paper 22 October 2009 Pages: 1060 - 1065

   

7. MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer

   • Bernard Paule
   • Vincent Castagne
   • Laurence Bonhomme-Faivre

   Original Paper 28 October 2009 Pages: 1066 - 1072

8. Clinicopathological analysis of primary epithelial appendiceal neoplasms

   • Sachin Gupta
   • Venkata Parsa
   • Bassel F. El-Rayes

   Original Paper 23 October 2009 Pages: 1073 - 1078

   

9. Intracranial tumor lysis and cerebral edema after administration of intrathecal methotrexate: a case report and discussion

   • Lohith S. Bachegowda
   • Petros D. Grivas
   • Kristine Ward

   Original Paper 22 October 2009 Pages: 1079 - 1081

   

10. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials

    • Jing Wang
    • Ping Zhan
    • Jian Ouyang

    Original paper 30 October 2009 Pages: 1082 - 1088

    

11. Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication

    • Yanlei Ma
    • Huanlong Qin
    • Zhe Yang

    Original Paper 03 November 2009 Pages: 1089 - 1095

    

12. Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1

    • Mansher Singh
    • Ambarish Pandey
    • Dinesh Rakheja

    Original Paper 27 October 2009 Pages: 1096 - 1101

    

13. Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer

    • Langmei Deng
    • Tao Su
    • Guiying Zhang

    Original Paper 03 November 2009 Pages: 1102 - 1108

    

14. Over-expression of Na⁺/H⁺ exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma

    • Xuekang Yang
    • Desheng Wang
    • Kefeng Dou

    Original Paper 30 October 2009 Pages: 1109 - 1113

    

15. Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells

    • Jie Yang
    • Yunxin Cao
    • Yong Zhang

    Original Paper 12 November 2009 Pages: 1114 - 1118

    

16. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes

    • Tadashi Terada

    Original Paper 27 October 2009 Pages: 1119 - 1122

    

17. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

    • Anna Czyz
    • Krzysztof Lewandowski
    • Mieczysław Komarnicki

    Original Paper 03 November 2009 Pages: 1123 - 1126

    

18. Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review

    • P. Dillon
    • N. Thomas
    • F. Collichio

    Original Paper 05 November 2009 Pages: 1127 - 1132

19. Pharmacogenetics and pharmacoepigenetics of gemcitabine

    • M. Candelaria
    • E. de la Cruz-Hernández
    • A. Dueñas-González

    Original paper 10 November 2009 Pages: 1133 - 1143

    

20. Large-cell neuroendocrine carcinoma of the ampulla of Vater

    • Z. Stojsic
    • D. Brasanac
    • I. Boricic

    Original Paper 07 November 2009 Pages: 1144 - 1148

    

21. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater

    • Seung Tae Kim
    • Jeeyun Lee
    • Won Ki Kang

    Original Paper 07 November 2009 Pages: 1149 - 1154

    

22. Retracted Article: Interleukin-1beta and tumor necrosis factor-alpha regulation of CDX2 homeobox gene through nuclear factor kappa B-dependent pathway in the intestinal-type gastric cancer

    • Jiang Li
    • Renhu Sun
    • Guobin Wang

    Original Paper 12 November 2009 Pages: 1155 - 1155

23. Antitumor effect of mSurvivinThr34 → Ala in murine colon carcinoma when administered intravenously

    • Hong-xia Li
    • Xin-yu Zhao
    • Xia Zhao

    Original Paper 01 December 2009 Pages: 1156 - 1163

    

24. Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters

    • Qi-Lian Liang
    • Bi-Rong Wang
    • Yan-Yun Xu

    Original Paper 12 November 2009 Pages: 1164 - 1170

    

25. A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients

    • Bo Ye
    • Shu-Geng Gao
    • Ke-Ling Sun

    Original Paper 24 November 2009 Pages: 1171 - 1178

    

26. Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells

    • Aimin Zhang
    • Yi Liu
    • Xiangtie Li

    Original Paper 17 November 2009 Pages: 1179 - 1184

    

27. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma

    • Tiefu Chen
    • Jie Zhu

    Original Paper 17 November 2009 Pages: 1185 - 1191

    

28. Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression

    • Yong Park
    • Myoung Hee Kang
    • Sang Cheul Oh

    Original paper 19 November 2009 Pages: 1192 - 1199

    

29. Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy

    • Xuxian Xiao
    • Qiongqiong He
    • Kelong Huang

    Original Paper 01 December 2009 Pages: 1200 - 1207

    

30. Pathologic complete response of a solitary melanoma brain metastasis after local ablative radiation therapy: case report

    • Steven Register
    • James W. Clarke
    • Simon S. Lo

    Original Paper 18 November 2009 Pages: 1208 - 1211

    

31. Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR

    • Marvin Rubenstein
    • Courtney M. P. Hollowell
    • Patrick Guinan

    Original Paper 24 November 2009 Pages: 1212 - 1218

    

32. Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor

    • Fei Liao
    • Weiguo Dong
    • Lifang Fan

    Original Paper 19 November 2009 Pages: 1219 - 1226

    

33. Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells

    • Yan He
    • Hui-qing Sun
    • Jian-hua Lei

    Original Paper 01 December 2009 Pages: 1227 - 1233

    

34. Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA)

    • Moon Ki Choi
    • Yeon Hee Park
    • Young-Hyuck Im

    Original Paper 19 November 2009 Pages: 1234 - 1238

    

35. mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients’ prognosis

    • Quan Zhou
    • Zhansheng Deng
    • Jiali Zhao

    Original Paper 20 November 2009 Pages: 1239 - 1245

    

36. Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer

    • Samir F. Zohny
    • Salah T. Fayed

    Original Paper 24 November 2009 Pages: 1246 - 1253

    

37. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil

    • L. C. O. Oliveira
    • L. G. M. Romano
    • G. C. De Santis

    Original Paper 25 November 2009 Pages: 1254 - 1259

    

38. Multimodality management for 145 cases of Merkel cell carcinoma

    • Patricia Tai
    • Edward Yu
    • Claude Krzisch

    Original Paper 01 December 2009 Pages: 1260 - 1266

    

39. Feasibility and activity for sequencing targeted therapies for the treatment of advanced renal cell carcinoma

    • Giuseppe Procopio
    • Elena Verzoni
    • Emilio Bajetta

    Original Paper 02 December 2009 Pages: 1267 - 1268

40. Liver transplantation for primary hepatic leiomyosarcoma: a case report and review of the literatures

    • Xiao Liang
    • Shi Xiao-Min
    • Li Rui-Dong

    Original paper 09 December 2009 Pages: 1269 - 1272

    

41. Polycomb group protein Bmi1 expression in colon cancers predicts the survival

    • Jianjun Du
    • Yongqi Li
    • Jianyong Zheng

    Original Paper 01 December 2009 Pages: 1273 - 1276

    

42. The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer

    • Seung Tae Kim
    • Jeeyun Lee
    • Young Suk Park

    Original Paper 01 December 2009 Pages: 1277 - 1285

    

43. Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence

    • Sanaa Eissa
    • Samir F. Zohny
    • Amany M. Maher

    Original Paper 11 December 2009 Pages: 1286 - 1294

    

44. Decreased expression of KLF6 and its significance in gastric carcinoma

    • Qing Zhang
    • Xiao-ping Tan
    • Nan-zhi Liu

    Original Paper 05 December 2009 Pages: 1295 - 1302

    

45. Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer

    • Yiqing Qu
    • Yie Yang
    • Wei Xiao

    Original Paper 10 December 2009 Pages: 1303 - 1308

    

46. Port central venous catheters–associated bloodstream infection during outpatient-based chemotherapy

    • Davide Mauri
    • Sofia Roumbkou
    • Nikolaos P. Polyzos

    original paper 05 December 2009 Pages: 1309 - 1313

47. Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study

    • Zi-Yu Li
    • Lei Tang
    • Jia-Fu Ji

    Original Paper 05 December 2009 Pages: 1314 - 1318

48. The association of serum adiponectin levels with histopathological variables in gastric cancer patients

    • Mesut Seker
    • Ahmet Bilici
    • Taflan Salepci

    Original Paper 16 December 2009 Pages: 1319 - 1323

    

49. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis

    • Fang Fang
    • Long Yu
    • Lei Yao

    Original Paper 10 December 2009 Pages: 1324 - 1328

    

50. Notch1 expression correlates with tumor differentiation status in ovarian carcinoma

    • Mingyi Wang
    • Jian Wang
    • Xiaoyan Xin

    Original Paper 11 December 2009 Pages: 1329 - 1335